Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Revenue (2022 - 2025)

Bioregenx's Revenue history spans 4 years, with the latest figure at $385641.0 for Q4 2025.

  • Quarterly results put Revenue at $385641.0 for Q4 2025, down 16.25% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (down 20.75% YoY), and the annual figure for FY2025 was $1.9 million, down 20.75%.
  • Revenue for Q4 2025 was $385641.0 at Bioregenx, down from $507755.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.1 million in Q1 2023 to a low of $7704.0 in Q1 2022.
  • The 4-year median for Revenue is $511451.0 (2025), against an average of $479231.4.
  • The sharpest move saw Revenue surged 13861.38% in 2023, then tumbled 48.91% in 2024.
  • Year by year, Revenue stood at $8914.0 in 2022, then soared by 7506.1% to $678008.0 in 2023, then crashed by 32.08% to $460489.0 in 2024, then fell by 16.25% to $385641.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $385641.0, $507755.0, and $445970.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.